DJIA 16,528.03 -114.98 -0.69%
NASDAQ 4,776.51 -51.82 -1.07%
S&P 500 1,972.18 -16.69 -0.84%
market minute promo

Merck & Co., Inc. (NYSE: MRK)

53.85 -1.52 (-2.75%)

REAL-TIME: Last trade at

Extended Hours: $53.84 -$0.01 (-0.01%)
Quote as of (NYSE)



company name or ticker

Recent Quotes

MRK $53.85 -2.75%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $55.12
Previous Close $55.37
Daily Range $53.62 - $55.30
52-Week Range $45.69 - $63.62
Market Cap $151.7B
P/E Ratio 16.33
Dividend (Yield) $1.80 (3.3%)
Ex-Dividend Date
Dividend Pay Date
09/11/15
10/07/15
Volume 12,617,712
Average Daily Volume 11,123,400
Current FY EPS $3.51

Sector

Healthcare

Industry

Drug Makers

Merck & Co., Inc. (MRK) Description

A global research-driven pharmaceutical company that discovers, develops, manufactures and markets a range of innovative products to improve human and animal health. Website: http://www.merck.com/

News & Commentary Rss Feed

Did This Clinical Study Just Show Merck's Best-Selling Drug the Door?

Are DPP-4 inhibitors like Januvia on their way out? A new long-term study from partners Eli Lilly and Boehringer Ingelheim suggests it's a possibility.

Chinese TCM: Regulated Cures Or Regulated Quackery?

The 4 Stocks That Hobbled the Dow on Monday

CELG, PFE, REGN, RCPT Jim Cramer's Views

An 80/20 Filter On How The DJIA Weathered The Week

The Zacks Analyst Blog Highlights: Merck & Co, Apple, Visa, Microsoft and Intel

Novo Nordisk to Start PIONEER Program on Semaglutide

5 Stocks That Led Dow to 3rd Biggest Gain

JNJ’s Splenda Sale Shouldn’t Be A Concern For Investors

Eli Lilly's Diabetes Drug May Halt Heart Disease

Eli Lilly's Jardiance was shown to reduce the risk of heart attack and stroke in diabetics.

See More MRK News...

MRK's Top Competitors

MRK $53.85 (-2.75%)
Current stock: MRK
JNJ $93.98 (-1.25%)
Current stock: JNJ
NVS $97.22 (-1.15%)
Current stock: NVS
RHHBY $34.16 (-0.01%)
Current stock: RHHBY